Cybersecurity and Dialysis Stocks Soar, Lithium Sinks

After-hours Stock Action
CrowdStrike ( $CrowdStrike(CRWD.US)$ ): Cybersecurity Juggernaut
- Post-Earnings Surge: Up over 20% after beating estimates and strong guidance.
- Stellar Performance: Stock up over 130% in the past year, outperforming First Trust Cybersecurity ETF ( $First Trust Exch Traded Fund 2 Nasdaq Cybersecurity Etf(CIBR.US)$ ).
Paccar ( $PACCAR Inc(PCAR.US)$ ): Record High on Price Target Hike
JPMorgan Boost: Reiterated overweight rating with a price target hike to $135 from $116.
Analyst Sentiment: Only 30% rate it a buy, while 55% rate it a hold; stock closed near $114.
DaVita & Fresenius: Positive Momentum
Dialysis Stocks Pop: DaVita up by 7%, Fresenius by 11%, reacting to latest Ozempic drug trial data.
Dexcom ( $DexCom(DXCM.US)$ ): FDA Clearance Boosts Stock
Health Care Mover: Slightly higher in extended session post-FDA clearance for OTC sales of continuous glucose monitor.
Albemarle & SQM: Sharp Declines in Lithium Sector
Albemarle Plunge: Worst S&P 500 performer down almost 18%, following capital raise announcement.
Peer Performance: SQM also fell sharply; both stocks down more than 50% in the past year. $Sociedad Quimica Y Minera De Chile(SQM.US)$